|
|
|
|
|
by DocG
1638 days ago
|
|
"In those aged 16–39 years, the rate of these severe outcomes was too small for meaningful estimation of the booster effectiveness. " Also, what I read is that the main D fference comes out from people who have multiple underlying conditions. I would like to read comparison data about non-vaccinated, vaccinated with two doses, vaccinated with three doses. The three dose is impressive compared to two doses when not comparing to non vaccinated. |
|